جست‌وجوی استاد و پژوهشگر

Anja Boisenمشاهده پروفایل

استاد

• Drug Delivery
• Sensing Technologies
• Nanotechnology
• +۳ مورد دیگر

Anja Boisen is a Professor and Head of the Drug Delivery and Sensing Section at the Department of Health Technology, Technical University of Denmark (DTU). Her research focuses on advanced drug delivery systems, sensing technologies, and nanotechnology applications in biomedical engineering. She leads a multidisciplinary team developing innovative devices such as microcontainers, microneedles, and lab-on-a-disc platforms for targeted drug delivery and diagnostics. Her work contributes to UN Sustainable Development Goals, particularly in improving health and reducing inequalities. Key research areas include surface-enhanced Raman spectroscopy (SERS), microfabrication for medical devices, and biomaterials for tissue engineering. She has supervised multiple PhD students, including projects on oral drug delivery systems, gastrointestinal retention devices, and energy-harvesting materials for biomedical applications. Boisen’s team has pioneered technologies like self-unfolding foils for oral delivery and smart drug delivery microparticles. Their innovations aim to enhance therapeutic efficacy while minimizing side effects. She has been recognized with the Sensor Division Outstanding Achievement Award (2022) for her contributions to sensor technology. Her lab actively collaborates internationally, advancing applications in cancer therapy, antibiotic monitoring, and gut microbiota research. Current projects explore high-throughput 3D tumor modeling, SERS-based diagnostics, and biodegradable materials for bone fixation.

Cristina Rosellمشاهده پروفایل

استاد

• Design and development of innovative grain-based foods
• Quality assessment of cereals and other grains
• Starch physical properties in foods
• +۷ مورد دیگر

Dr. Cristina Rosell is a Professor and Head of the Department of Food and Human Nutritional Sciences at the Faculty of Agricultural and Food Sciences, University of Manitoba. Her research focuses on grain-based food innovation, starch properties, and sustainable bakery processes. Education: PhD and BSc in Pharmacy from Universidad Complutense de Madrid, Spain Dr. Rosell specializes in cereal science, enzymatic food modification, and gluten-free product development. Her current projects include optimizing bakery processes with computational tools, tracing rice supply chains via blockchain, and integrating bioactives into gluten-free foods. Her work bridges food chemistry, nutritional science, and industrial bakery technology. Her recent research trends emphasize gluten-free bread using legume and root starches, starch-plant compound interactions , and sustainable food processing via microwave-assisted extraction, high-pressure treatments, and fermentation. Key subfields include dough rheology, polyphenol bioactivity, and techno-functional ingredient development. Dr. Rosell’s teaching includes graduate seminars in food science (HNSC 7130). She supervises graduate students in breadmaking, starch hydrolysis, and functional food design. Her lab explores grain quality, enzymatic treatments, and bakery product optimization through interdisciplinary approaches combining chemistry, nutrition, and process engineering.

• Nanomedicine
• Drug Delivery Systems
• Cellular Uptake of Nanoparticles
• +۳ مورد دیگر

Anna Salvati is an Associate Professor specializing in nanomedicine and drug delivery systems. Her research focuses on nanoparticle-cell interactions, biomolecular corona formation, and the physicochemical properties governing nanomaterial behavior in biological environments. Key research themes include cellular uptake mechanisms, toxicity of nanomaterials, and nanoparticle targeting strategies. Recent publications highlight her work on nanoparticle stability, membrane interactions, and environmental impacts of microplastics. Her studies integrate multiomics approaches, advanced imaging, and interlaboratory validation to address challenges in nanomedicine design and safety testing. Current projects explore the role of high-density lipoproteins in nanoparticle functionality and the modulation of drug release kinetics through material engineering.

Hang Luمشاهده پروفایل

دانشیار

• Science Communication
• Health Communication
• Environmental Communication
• +۴ مورد دیگر

Hang Lu is an Associate Professor in the Department of Communication and Media at the University of Michigan's College of Literature, Science, and the Arts. He specializes in science, health, environmental, and risk communication (ComSHER), with a focus on media psychology. His research explores audience responses to media messages about sensitive topics and strategies to enhance message effectiveness. Lu holds a Ph.D. in Communication from Cornell University (2018), along with advanced degrees from Cornell, Marquette University, and Central South University in China. He directs the Media and Risk (MaR) Lab and previously served as a postdoctoral fellow at the Annenberg Public Policy Center. His research spans four main areas: 1) emotion dynamics in media responses, 2) predictors of information behaviors, 3) media effects on stigmatization, and 4) AI applications in sensitive domains. He has published in journals like Journal of Communication , Risk Analysis , and Public Understanding of Science , earning multiple top paper awards. As Vice Chair of the Environmental Communication Division at the International Communication Association, Lu contributes to interdisciplinary dialogue. His work addresses critical societal issues such as climate change communication, vaccination hesitancy, and emerging technology ethics.

Jessica Rosenholmمشاهده پروفایل

استاد

• Drug Delivery Systems
• Nanomedicine
• Biomaterials Engineering
• +۶ مورد دیگر

Jessica Rosenholm is a Professor at the Faculty of Science and Engineering, Department of Pharmacy at Åbo Akademi University. Her research focuses on drug delivery systems, nanomedicine, and biomaterials engineering. She holds a D.Sc.(Tech.) and has authored over 200 publications. Key research areas include mesoporous silica nanoparticles, 3D bioprinting, and antimicrobial resistance solutions. Her work contributes to UN Sustainable Development Goals, particularly in advancing health technologies. Notable achievements include the Akzo Nobel Nordic Research Prize 2009 and the Knight, First Class, of the Order of the White Rose of Finland (2022). She leads projects like the MADNESS Centre of Excellence, exploring materials-driven solutions against antimicrobial resistance. Education: Doctor of Science (Technology) Research Interests: Nanoformulations, biomedical imaging, microfluidics, and tissue engineering. Recent articles highlight innovations in programmable nanocomposites for hearing loss treatment, microfluidic assembly of nanostructures, and 3D printing of drug delivery systems. Awards: ÅAU Chancellor’s Prize (2013), Forskarpriset ur Harry Elvings legat (2009) Grants: Projects funded by EU, Finnish Research Council, and Sigrid Jusélius Foundation. Labs/Teams: BioNanoMaterials group explores cutting-edge technologies like nanomedical agents and microfluidics. Current projects include the NAP4DIVE initiative for blood-brain barrier drug delivery.

Katrin Gillerمشاهده پروفایل

استاد

• Nutritional Sciences
• Animal Nutrition
• Molecular Nutrition
• +۳ مورد دیگر

Prof. Dr. habil. Katrin Giller leads the Department of Molecular Nutrition Science (140a) at the University of Hohenheim, Garbenstraße 30, Bio Building I, Room 151, Stuttgart. Her research focuses on livestock nutrition, with specific interests in methane mitigation, antioxidant mechanisms, and metabolic syndrome in agricultural animals. Department: Molecular Nutrition Science (140a) Contact: katrin.giller@uni-hohenheim.de Office Hours: By appointment Her work spans nutritional biochemistry , ruminal fermentation , and sustainable livestock systems , often examining interactions between dietary compounds (e.g., spirulina, polyphenols, n-3 fatty acids) and animal physiology. Recent studies investigate antioxidant gene expression , transgenerational metabolic impacts , and feed efficiency . Current advisees include B.Sc. Viola Gauly, Fernando Giugno, Jana Kornherr, Mira Kühn, Daniel Obermüller, and Helen Pötzsch. The department's website details research projects, teaching events, and publications.

Michel Versluisمشاهده پروفایل

استاد

• Physical and Medical Acoustics
• Microbubbles
• Microdroplets
• +۵ مورد دیگر

Michel Versluis is a Full Professor at the University of Twente, Netherlands, specializing in Physical and Medical Acoustics within the Physics of Fluids group. His work focuses on microbubbles and microdroplets for medical imaging and therapy, as well as microfluidic applications in medicine and nanotechnology. University of Twente, Physics of Fluids group His research bridges physics and biomedical engineering, with publications in high-impact journals like PNAS and IEEE Transactions. Recent work emphasizes ultrasound-driven microbubble dynamics, additive manufacturing of flow phantoms, and deep learning for super-resolution imaging. 2025 publications: vascular phantoms, PROTEUS simulator, acoustic microbubble control 2024 innovations: 3D-printed medical devices, immunogenic cell death optimization Contact: m.versluis@utwente.nl

Xian Wuمشاهده پروفایل

استادیار

• Developmental Toxicology
• Stem Cell Models
• Neurotoxicology
• +۵ مورد دیگر

Xian Wu, Ph.D., serves as a Research Assistant Professor in the Department of Pharmacology & Toxicology at East Carolina University's Brody School of Medicine. Her research leverages human stem cell models to investigate developmental vulnerabilities to environmental contaminants in cardiovascular and neural systems, with emphasis on epigenetic mechanisms and disease modeling. Dr. Wu's academic credentials include: Ph.D. in Toxicology from the University of Georgia M.S. in Biomedicine from East China Normal University B.S. in Biotechnology from Anhui University Her postdoctoral training comprised a Fellowship at the National Institute of Environmental Health Sciences and an ORISE Fellowship at the U.S. Food and Drug Administration. Research focuses on creating human stem cell-derived organoid systems to model developmental toxicology, particularly examining cardiac and neural development under chemical exposure. The laboratory employs fluorescence reporter systems and RNA-seq to identify critical vulnerability windows during early development, with recent work targeting Parkinson's disease mechanisms through dopaminergic neuron models and cardiac fibrosis via advanced organoids. Methodological innovations include high-content imaging for neurogenesis quantification and epigenetic pathway analysis. Publication trends (2016-2025) demonstrate consistent advancement in stem cell-based toxicology testing, with increasing emphasis on micro/nanoplastics risk assessment, arsenic neurotoxicity mechanisms, and doxorubicin cardiotoxicity modeling. The work bridges environmental health, epigenetics, and regenerative medicine through interdisciplinary approaches. Scientific recognition includes: 2025 SPARC Award (ECU) 2024 Top Abstract Award (Developmental Origins of Health and Disease Society) 2024 NIEHS P30 Center Travel Award 2023 ECU Research and Creative Activity Award Dr. Wu actively mentors graduate researchers including Ph.D. candidate Cate Duncan and M.S. students Kamilah Muhammad and Bailey Skeen, alongside undergraduate Bryce Tilghman. Former trainees McKyrah Brown and Monica Cross completed honors theses in the laboratory. Current grants include ECU's SPARC Award funding stem cell model development for environmental contaminant testing. The BSOM 6S-11 laboratory maintains specialized capabilities in cardiac and cerebral organoid generation, fluorescence-based toxicity screening, and RNA-seq epigenetic analysis. Collaborative networks include the National Institute of Environmental Health Sciences and ECU's Center for Human Health and the Environment, supporting translational research on developmental vulnerability periods.

• Drug Delivery
• Pharmaceutics
• Nanomedicine
• +۵ مورد دیگر

Caitriona M. O'Driscoll is Professor and Chair of Pharmaceutics at University College Cork's School of Pharmacy, Ireland. With over four decades of academic experience, she previously served as Head of the School of Pharmacy at UCC from 2003-2009 and 2010-2013. Her established drug delivery research team spans from pre-formulation through to production and manufacture of prototype delivery systems suitable for clinical trial, with strong industry links underpinning many research projects. Her research interests focus on translational drug delivery with emphasis on 'problem' drugs including poorly water soluble compounds and biopharmaceuticals like peptide/protein drugs, plasma DNA and siRNA. She develops nano-sized delivery constructs that are robust enough to survive processing, stable on storage, and achieve cell/site specific delivery in vivo. Greater than 40% of new chemical entities are poorly water soluble Biopharmaceuticals now approach 50% of all new drugs in development Major barrier is design of efficient delivery systems Special focus on oral drug delivery despite challenges Analysis of her recent publications reveals a strong emphasis on targeted nanodelivery systems for cancer therapy, particularly prostate and colorectal cancer, as well as neurodegenerative diseases like Huntington's. Her work demonstrates expertise in cyclodextrin-based nanoparticles, siRNA delivery, and disease-specific formulations that account for conditions like Crohn's disease that affect drug delivery. Scientific awards include: 'Person of the Year award' by Parenteral Drug Association (Ireland Chapter) in 2013 'Award for Professional Excellence' by Helix Health in 2007/2008 'Award for Pharmacist of the Year' by Helix Health in 2007/2008 With €10.5M in career research income and 25 PhDs graduated, Professor O'Driscoll's work has attracted funding from diverse sources including Science Foundation Ireland, Enterprise Ireland, and industry partners. Her research group maintains strong links with Pharmaceutical Chemistry and Process & Chemical Engineering at UCC, creating a unique strength for drug development research from design through to clinical trial. She has served as external examiner for multiple universities and as PhD thesis examiner at institutions worldwide. Her research team operates within UCC's drug delivery group, which has established expertise spanning from pre-formulation through to production and manufacture of prototype delivery systems. The group maintains strong industry connections and offers various PhD positions, focusing particularly on translational research with product-driven applications.

Steven R. Caliariمشاهده پروفایل

دانشیار

• Biomaterials
• Mechanobiology
• Musculoskeletal Tissue Engineering
• +۱ مورد دیگر

Steven R. Caliari is an Associate Professor in the Department of Chemical Engineering with a secondary appointment in Biomedical Engineering at the University of Virginia’s School of Engineering and Applied Science. He serves as the ChE Graduate Program Director and is a SEAS Copenhaver Fellow (2023). His research focuses on designing biomaterials to study cell-microenvironment interactions, addressing challenges in disease and tissue engineering. He holds a B.S. (2007, University of Florida), M.S. (2010), and Ph.D. (2013) in Chemical Engineering from the University of Illinois, followed by an NIH postdoctoral fellowship at the University of Pennsylvania. His research interests include biomaterials, mechanobiology, musculoskeletal tissue engineering, and advanced manufacturing for biological applications. His lab has pioneered viscoelastic hydrogel platforms and conductive collagen scaffolds, supported by NIH, NSF, DoD, and industry grants. Notable awards include the NSF CAREER Award (2021) and NIH MIRA (2020). Grants: NIH (NIGMS), NSF CAREER, V Foundation, UVA-Coulter Partnership Courses: Tissue Engineering (BME/CHE 4417), Transport Processes I (CHE 3321) Labs: Caliari Lab focuses on biomaterial design and mechanobiological studies His work bridges fundamental science and translational applications, emphasizing dynamic material systems for regenerative medicine and disease modeling.

Nicholas M. Kanaanمشاهده پروفایل

استاد

• Neurodegenerative Diseases
• Alzheimer's Disease
• Parkinson's Disease
• +۶ مورد دیگر

Nicholas M. Kanaan is a Professor of Translational Neuroscience and holds the Maibach Smiley Professorship of Alzheimer's Research at Michigan State University's College of Human Medicine. He serves as Director of Advanced Microscopy and is faculty in both the MSU Neuroscience Program and the MSU BioMolecular Science Gateway. His research is centered at the Grand Rapids Research Center where he leads the Kanaan Laboratory. Dr. Kanaan received his B.S. in Neuroscience, Psychology, and Sociology from Central Michigan University in 2001, followed by a Ph.D. in Neurological Sciences from Rush University Medical Center in 2007. He completed postdoctoral training at Northwestern University from 2007-2010 under Dr. Lester Binder. His research focuses on neurodegenerative diseases, particularly Alzheimer's disease (AD) and Parkinson's disease (PD), with emphasis on tau protein pathology. The Kanaan Lab investigates mechanisms underlying degenerative diseases using a combination of in vitro and in vivo model systems. A major focus is understanding how disease-related alterations in tau cause neuronal dysfunction through disruption of axonal transport. His lab has identified a phosphatase-activating domain (PAD) in tau that inhibits anterograde fast axonal transport. Analysis of Dr. Kanaan's publication record reveals a consistent focus on tau protein biology, with recent work emphasizing iPSC models, CRISPR screening, tau proteostasis, and therapeutic interventions targeting tau phosphorylation and oligomerization. His research spans basic molecular mechanisms to translational applications, with increasing use of primate models and advanced screening technologies in recent years. Scientific Awards and Recognition: Maibach Smiley Alzheimer's Research Professor Maibach Smiley Professor of Alzheimer's Research Dr. Kanaan mentors numerous students and postdoctoral fellows in his laboratory, with research supported by multiple grants focused on understanding and treating neurodegenerative diseases. His lab employs a wide range of technical expertise including recombinant protein purification, cell culture, monoclonal antibody production, various microscopy techniques, and behavioral testing in rodent models. Outside the lab, Dr. Kanaan enjoys photography, woodworking, and fishing.

• Periodontology
• Preventive Dentistry
• Oral Health
• +۶ مورد دیگر

Thomas Beikler serves as a Professor in the Department of Periodontology, Preventive Dentistry and Dental Conservation at the University Medical Center Hamburg-Eppendorf (UKE), which operates under the Faculty of Medicine. His academic credentials include dual doctoral degrees as indicated by his title 'Univ.Prof.Dr.Dr.' Dr. Beikler's research spans multiple dimensions of periodontal science and oral-systemic health connections. His work investigates the relationship between periodontal disease and various systemic conditions including hypophosphatasia, liver cirrhosis, depression, and neurological changes. He has made significant contributions to understanding oral health literacy, particularly among German adult populations with migration backgrounds through the MuMi Study. His research methodology frequently employs large population-based studies like the Hamburg City Health Study to establish epidemiological connections between oral and general health. His publication record demonstrates a strong interdisciplinary approach, bridging dentistry with neurology, hepatology, psychiatry, and public health. Notable research directions include microbiome-based therapies for periodontitis, the role of biomarkers in oral health assessment, and the development of innovative dental education models in Germany. Dr. Beikler has led significant research projects including the 'Transplantation of a healthy oral donor microbiome for periodontal therapy' (2016-2019), which explored cutting-edge approaches to treating periodontal disease. He has also contributed to dental education reform through the iMED DENT program, Germany's first model dental study program.

Emine Ayazمشاهده پروفایل

استاد

• Electrical Engineering
• Mechanical Fault Detection
• Signal Processing
• +۱۲ مورد دیگر

Emine Ayaz is a Professor at Istanbul Technical University's Department of Electrical Engineering. Her research spans fault detection in electric motors, signal processing, and nuclear power plant monitoring, with recent work integrating deep learning (e.g., dual RNN architectures) and medical applications (e.g., parasitology, plant-based wound healing). Key Collaborations : International partnerships in motor diagnostics and nuclear engineering. Projects : Led grants on high-voltage training and predictive maintenance for TEİAŞ and industrial processes. Research Trends : Recent publications emphasize neural networks for motor fault classification, coherence analysis for insulation diagnostics, and interdisciplinary work in plant biotechnology and parasitology. Labs & Teams : Involved in projects analyzing vibration signals, wavelet transforms, and sensor fusion for industrial and nuclear systems.

Ravi Shuklaمشاهده پروفایل

استاد

• Nanobiotechnology
• Bioscience
• Medical Biotechnology
• +۶ مورد دیگر

Professor Ravi Shukla is a faculty member at RMIT University's School of Science, holding the title of Professor and Deputy Head of Department (Research). He specializes in Nanobiotechnology, with research spanning biomaterials, drug delivery systems, and medical diagnostics. His work integrates biosciences, materials science, and food technology to advance understanding of nanomaterial-biomolecular interactions. Academic History: Professor Shukla has held roles at RMIT since 2011, progressing from Research Fellow to his current professorship. He also serves as an Adjunct Professor at the University of Missouri and Theme Leader for Nanobiotechnology at RMIT’s Center for Advanced Materials and Industrial Chemistry. His teaching focuses on fostering student belonging and innovation in biotechnology education, including coordinating RMIT’s undergraduate Biotechnology program. Research Interests: His lab explores hybrid biomaterial synthesis, nano-enabled proteomics, and non-viral gene therapy using MOFs. Recent work emphasizes applications in diabetes biosensing, CRISPR/Cas9 delivery, and antimicrobial resistance mitigation through nanostrategies. Over 130+ publications and substantial research funding highlight his interdisciplinary impact. Professional Engagement: Editor roles in Frontiers in Bioengineering and Biotechnology , Co-Editor-in-Chief of Current Research in Nutrition and Food Science , and advisor to the Australasian Association of Ayurveda underscore his leadership. He actively mentors students in projects like nano-antimicrobial wound healing and aptamer-based hepatitis A detection. Key Achievements: Pioneered nucleic acid-encapsulated MOFs for cancer therapy and developed paper-based biosensors for rapid diagnostics. His work aligns with UN Sustainable Development Goals 2 (Zero Hunger) and 3 (Good Health).

Marc Schneiderمشاهده پروفایل

استاد

• Colloidal drug delivery systems
• Nanoparticle and microparticle engineering
• Nanotechnology in pharmacy
• +۳ مورد دیگر

Prof. Dr. Marc Schneider holds a professorship in Biopharmaceutics and Pharmaceutical Technology at Saarland University's College of Pharmacy . His research focuses on colloidal drug delivery systems, particularly nanostructured and non-spherical particle engineering for overcoming biological barriers in pulmonary and transdermal applications. He leads an internationally recognized lab in Saarbrücken, collaborating with Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and trinational institutions. Research Highlights: Development of inhalable nano/microparticle systems Surface modification of gelatin nanoparticles Characterization of mucus-penetrating particles 3D printing for microneedle fabrication Atomic Force Microscopy (AFM) for nanoparticle analysis Selected Scientific Awards: European Journal of Pharmaceutics and Biopharmaceutics Best Paper Award (2018) for mucus-penetrating nanoparticles Recognized in 'Ausgezeichnete Orte im Land der Ideen' competition (2018) for 'Nano-Mais' drug delivery system Collaborative Networks: Co-editor for Advanced Drug Delivery Reviews special issue on biological barriers Key participant in trinational Master's program in Biomedicine with Strasbourg, Mainz, and Luxembourg Active in Controlled Release Society (CRS) conferences and local chapters